Nearly 18 months after the FDA first acknowledged a national shortage of Adderall, there is now a widespread scarcity of multiple ADHD medications with no end in sight.
Initiating drug treatment for ADHD is linked to significantly lower all-cause mortality, particularly for deaths caused by accidental poisoning, suicide, or accidental injury.
Concerns have been raised that teens who take stimulants for ADHD may have an increased risk for prescription drug misuse, but this study found no such association.
New data show more than 1 in 10 young people have a mental health disorder, raising concern about the potential lifelong impact of anxiety, depression, and other psychiatric disorders.
Unravel the narratives of physicians who defy stereotypes and navigate the complexities of healthcare as they challenge the stigma and grapple with ADHD.